Cogent Biosciences, Inc. (COGT)
Cogent Biosciences Market Cap : 4.775B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 4.775B |
| November 13, 2026 | 4.970B |
| November 12, 2026 | 5.071B |
| November 11, 2026 | 5.116B |
| November 10, 2026 | 5.506B |
| November 09, 2026 | 5.837B |
| November 06, 2026 | 5.507B |
| November 05, 2026 | 5.148B |
| November 04, 2026 | 5.480B |
| November 03, 2026 | 5.405B |
| November 02, 2026 | 5.103B |
| October 30, 2026 | 5.324B |
| October 29, 2026 | 5.486B |
| October 28, 2026 | 5.532B |
| October 27, 2026 | 5.494B |
| October 26, 2026 | 5.305B |
| October 23, 2026 | 5.357B |
| October 22, 2026 | 5.374B |
| October 21, 2026 | 5.395B |
| October 20, 2026 | 5.362B |
| October 19, 2026 | 5.151B |
| October 16, 2026 | 5.067B |
| October 15, 2026 | 5.065B |
| October 14, 2026 | 4.832B |
| October 13, 2026 | 4.821B |
| Date | Value |
|---|---|
| October 12, 2026 | 5.112B |
| October 09, 2026 | 5.321B |
| October 08, 2026 | 5.163B |
| October 07, 2026 | 5.173B |
| October 06, 2026 | 5.214B |
| October 05, 2026 | 5.299B |
| October 02, 2026 | 5.324B |
| October 01, 2026 | 5.422B |
| September 30, 2026 | 5.496B |
| September 29, 2026 | 5.434B |
| September 28, 2026 | 5.469B |
| September 25, 2026 | 5.546B |
| September 24, 2026 | 5.395B |
| September 23, 2026 | 5.391B |
| September 22, 2026 | 5.601B |
| September 21, 2026 | 5.493B |
| September 18, 2026 | 5.407B |
| September 17, 2026 | 5.697B |
| September 16, 2026 | 5.585B |
| September 15, 2026 | 5.620B |
| September 14, 2026 | 5.735B |
| September 11, 2026 | 5.735B |
| September 10, 2026 | 5.850B |
| September 09, 2026 | 5.867B |
| September 08, 2026 | 6.056B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Moderna, Inc. | 86.97B |
| Oncolytics Biotech, Inc. | 44.94M |
| Sangamo Therapeutics, Inc. | 45.11M |
| Sarepta Therapeutics, Inc. | 1.622B |
| Anixa Biosciences, Inc. | 88.19M |
Market Cap Related Metrics
| PEG Ratio | -2.873 |
| Price to Book Value | 10.58 |
| Price | 27.44 |
| Earnings Yield | -9.11% |
| PEGY Ratio | -2.873 |